top of page

Screen Shot 2021-01-12 at 11.44.35 AM.pn

Search

A2A Pharma takes residence

A2A Pharma
May 16, 2019
1 min read

Updated: Feb 7, 2020

A2A Pharma takes residence at JLABS@NYC

LEARN MORE

Recent Posts

FDA Clearance of IND Application for TACC3 PPI Inhibitor A2A-252 in Women's Cancer

FDA Clearance of IND Application for TACC3 PPI Inhibitor A2A-252 in Women's Cancer

A2A co-founded biomea Fusion raises $56M

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations...

A2A / Daewoong Pharmaceutical Oncology Agreement

A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology...

Comments

bottom of page